Enrolling Minors in COVID-19 Vaccine Trials.
Pediatrics
; 147(3)2021 03.
Article
in English
| MEDLINE | ID: covidwho-992774
ABSTRACT
It is widely agreed that an effective response to the coronavirus disease 2019 pandemic needs to include a vaccine that is safe and effective for minors. However, many current vaccine trials have no plans for when to enroll minors. Others have recently proposed enrolling minors as young as 12 years old. This lack of a systematic approach raises 2 concerns. Waiting too long to enroll minors could unjustly deny minors and their families the benefits of a vaccine and has the potential to delay an effective response to the pandemic by a year or longer. At the same time, enrolling minors too soon runs the risk of exposing them to excessive risks. With these concerns in mind, in the present article, we propose recommendations for when and how to enroll minors in vaccine trials for the coronavirus disease 2019.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Clinical Trials as Topic
/
Minors
/
Healthy Volunteers
/
COVID-19 Vaccines
Type of study:
Prognostic study
/
Randomized controlled trials
/
Systematic review/Meta Analysis
Topics:
Vaccines
Limits:
Adolescent
/
Child
/
Humans
Language:
English
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS